Blackstone stock closes higher as Barclays trims target; CPI and earnings loom
10 January 2026
2 mins read

Blackstone stock closes higher as Barclays trims target; CPI and earnings loom

NEW YORK, Jan 10, 2026, 17:06 EST — Market closed

  • Shares of Blackstone climbed 1.5% on Friday, closing at $157.62
  • Barclays lowered its price target for Blackstone to $171 but maintained an “equal weight” rating
  • Investors are focused on the U.S. CPI release set for Jan. 13 and Blackstone’s earnings report due Jan. 29

Blackstone Inc (BX.N) shares climbed 1.5% on Friday, closing at $157.62 after fluctuating between $154 and $158.26 during the session. Barclays cut its price target slightly to $171 from $172 but maintained an “equal weight” rating, signaling a neutral stance on the stock.

This shift is significant since Blackstone operates where markets meet dealmaking. Once stocks and credit stabilize, exits become smoother and fundraising usually picks up.

Timing plays a role too. Investors are aligning macro data with the kickoff of earnings season, hunting for any rate fluctuations that might shake valuations in private equity, real estate, and credit.

U.S. stock indexes hit record highs on Friday following data that revealed December job gains fell short of expectations, while the unemployment rate slipped to 4.4%, Reuters reported. Investors kept an eye on the U.S. Supreme Court’s tariff case, with new rulings anticipated on Jan. 14, according to the report. “Payrolls were a little bit light relative to consensus, but still fairly strong,” said Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder.

Peers closed the session split, highlighting selective money flows within the group. KKR rose 0.7%, Carlyle climbed 1.1%, while Apollo dipped 0.2%.

Outside of BX’s own trades, Blackstone continues to unload shares steadily. Legence confirmed that underwriters fully exercised the over-allotment option—a “greenshoe” allowing banks to sell extra shares when demand is strong—linked to a secondary offering by Blackstone-affiliated sellers. This option added 1,260,326 Legence shares, priced at $45 apiece. Legence made clear it didn’t sell any stock itself or receive proceeds from this. 1

Despite Friday’s rebound, Blackstone’s share price still sits roughly 17% under its 52-week peak of $190.09. Volume for the session came in below the stock’s 50-day average, according to MarketWatch data. 2

Tuesday brings the U.S. consumer price index for December at 8:30 a.m. ET, a data point that could swiftly alter expectations around rate cuts. The Federal Reserve’s next policy meeting is scheduled for Jan. 27-28.

Blackstone is set to release its fourth-quarter and full-year 2025 results on Jan. 29 at 9:00 a.m. ET. Investors are eager for updates on fundraising, asset sales, and fee-related earnings, along with any change in management’s tone on deploying capital into private credit and real estate.

There are a few sharp edges in the setup. On Friday, the U.S. Supreme Court chose not to rule on the legality of President Donald Trump’s broad tariffs, leaving investors in limbo. At the same time, U.S. stock valuations remain elevated as earnings season approaches, Reuters reported.

Blackstone’s focus shifts to Monday’s reopening, with the CPI report due Jan. 13 next on the radar. After that, all eyes will be on the earnings call scheduled for Jan. 29.

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Qualcomm (QCOM) stock drops after Mizuho downgrade flags Apple modem risk
Previous Story

Qualcomm (QCOM) stock drops after Mizuho downgrade flags Apple modem risk

Inditex stock slips into weekend — what could move Zara owner shares next
Next Story

Inditex stock slips into weekend — what could move Zara owner shares next

Go toTop